Ocular surface disease in thyroid eye disease: A narrative review. Ocul Surf 2022 Apr;24:67-73
Date
02/16/2022Pubmed ID
35167950Pubmed Central ID
PMC9058200DOI
10.1016/j.jtos.2022.02.001Scopus ID
2-s2.0-85124553276 (requires institutional sign-in at Scopus site) 42 CitationsAbstract
Ocular surface disease (OSD) in the setting of thyroid eye disease (TED) is traditionally thought of as a natural consequence of anatomical changes such as proptosis and corneal exposure. However, a growing body of research suggests that ocular surface inflammation and multi-factorial changes to the homeostasis of the ocular surface contribute substantially to the OSD seen in TED patients. In this paper we review the existing literature which highlights the work and existing theories underlying this new paradigm shift.
Author List
Rana HS, Akella SS, Clabeaux CE, Skurski ZP, Aakalu VKAuthor
Vinay Kumar Aakalu MPH, MD Chair, Professor in the Ophthalmology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
EyeGraves Ophthalmopathy
Humans
